Zhang Weiyue, Huang Xin
Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Mater Today Bio. 2022 Aug 1;16:100377. doi: 10.1016/j.mtbio.2022.100377. eCollection 2022 Dec.
Cell membrane-coated nanoparticles (NPs) have attracted growing attention in the field of targeted delivery strategies, which successfully combine the advantages and properties of both cell membranes and synthetic NPs. Stem cell-based delivery systems have the innate targeting capability to tumor tissues, but inappropriate stem cells might promote tumor growth after being injected into the body. Accordingly, it is urgent to explore novel drug delivery systems that might combine the advantages of stem cells and eliminate the possible risks. This review aimed to investigate the stem cell membrane-camouflaged targeted delivery system in tumors. We discussed the underlying mechanisms of stem cell homing to target tumors. Then, the common membrane modification methods well as preparation methods of stem cell membrane coated NPs were concluded. NPs coating the stem cell membranes could obtain the tumor targeting ability, enhanced biocompatibility, and effective drug loading. Furthermore, we investigated the potential clinical applications of mesenchymal stem cells (MSCs) and induced pluripotent stem (iPS) cells membrane-camouflaged targeted delivery systems for anti-tumor therapies, such as chemotherapy, photodynamic therapy, magnetic hyperthermia therapy and imaging, CRISPR-Cas9 gene therapy, and synergistic therapy. Taken together, stem cell membrane-coated NPs hold the tremendous prospect for biomedical applications in tumor therapy.
细胞膜包覆纳米颗粒(NPs)在靶向递送策略领域受到越来越多的关注,它成功地结合了细胞膜和合成纳米颗粒的优点及特性。基于干细胞的递送系统对肿瘤组织具有天然的靶向能力,但不合适的干细胞注入体内后可能会促进肿瘤生长。因此,迫切需要探索一种既能结合干细胞优势又能消除潜在风险的新型药物递送系统。本综述旨在研究肿瘤中干细胞膜伪装的靶向递送系统。我们讨论了干细胞归巢至靶向肿瘤的潜在机制。然后,总结了常见的膜修饰方法以及干细胞膜包覆纳米颗粒的制备方法。包覆干细胞膜的纳米颗粒可获得肿瘤靶向能力、增强的生物相容性和有效的药物负载能力。此外,我们研究了间充质干细胞(MSCs)和诱导多能干细胞(iPS)细胞膜伪装的靶向递送系统在抗肿瘤治疗中的潜在临床应用,如化疗、光动力疗法、磁热疗和成像、CRISPR-Cas9基因治疗以及协同治疗。综上所述,干细胞膜包覆纳米颗粒在肿瘤治疗的生物医学应用中具有巨大的前景。